Magnetic Resonance Imaging and Spectroscopy of the Prostate

Memorial Sloan Kettering Cancer Center1 site in 1 country1,005 target enrollmentDecember 2000

ConditionsProstate Cancer

Overview

Phase: N/A
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Enrollment: 1005
Locations: 1
Primary Endpoint: Determine added value in combining MRSI and MRI in prostate cancer treatment
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.

Registry

clinicaltrials.gov

Start Date

December 2000

End Date

February 2013

Last Updated

2 years ago

Study Type

Observational

Sex

Male